Obesity-induced inflammation is thought to be the mechanism leading to IR and NAFLD [52], and HFD inhibits phosphorylation of AMPK-TBC1D1 signaling, increases protein levels of PPARγ, and ultimately promotes hepatic fat accumulation [53]. The gene discussed is TBC1D1; the disease is metabolic dysfunction-associated steatotic liver disease.